LAVA THERAPEUTICS NV (LVTX)
NL0015000AG6 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to LVTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.94. This target is 127.41% above the current price.
LVTX was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about LVTX.
In the previous month the buy percentage consensus was at a similar level.
LVTX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-23 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-06-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-09 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-04-13 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-25 | HC Wainwright & Co. | Initiate | Buy |
| 2022-09-27 | SVB Leerink | Maintains | Outperform |
| 2022-09-15 | JMP Securities | Initiate | Market Outperform |
| 2022-05-18 | SVB Leerink | Maintains | Outperform |
| 2021-11-16 | SVB Leerink | Maintains | Outperform |
| 2021-08-17 | SVB Leerink | Maintains | Outperform |
| 2021-04-19 | SVB Leerink | Initiate | Outperform |
| 2021-04-19 | JP Morgan | Initiate | Overweight |
| 2021-04-19 | Jefferies | Initiate | Buy |